CorMedix Inc. CRMD
$8.64
▼ -2.46% 24H
About
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening conditions, particularly in anti-infective therapies and hospital-based treatments in the United States. Its lead product, DefenCath, is an FDA-approved antimicrobial catheter lock solution c…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees64
TickerCRMD
Statistics
Market Cap$677.7M
Revenue (TTM)$311.7M
Net Income$163.1M
Net Margin52.3%
EPS$2.04
P/E4.04
P/S1.72
P/B1.57
EV/EBITDA2.87
ROE65.6%
Dividend Yield—
Price$8.64
Data: Twelve Data · Revenue = mcap / P/S